65 related articles for article (PubMed ID: 20126732)
1. Small molecule probes that target Abl kinase.
Kalesh KA; Sim DS; Wang J; Liu K; Lin Q; Yao SQ
Chem Commun (Camb); 2010 Feb; 46(7):1118-20. PubMed ID: 20126732
[TBL] [Abstract][Full Text] [Related]
2. An intramolecular SH3-domain interaction regulates c-Abl activity.
Barilá D; Superti-Furga G
Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
[TBL] [Abstract][Full Text] [Related]
3. Detection of c-Abl kinase-promoted phosphorylation of Rad51 by specific antibodies reveals that Y54 phosphorylation is dependent on that of Y315.
Popova M; Shimizu H; Yamamoto K; Lebechec M; Takahashi M; Fleury F
FEBS Lett; 2009 Jun; 583(12):1867-72. PubMed ID: 19427856
[TBL] [Abstract][Full Text] [Related]
4. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.
Mysliwiec T; Perego R; Kruh GD
Oncogene; 1996 Feb; 12(3):631-40. PubMed ID: 8637720
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
Jung JH; Pendergast AM; Zipfel PA; Traugh JA
Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
[TBL] [Abstract][Full Text] [Related]
6. Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
Juang JL; Hoffmann FM
Oncogene; 1999 Sep; 18(37):5138-47. PubMed ID: 10498863
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
Brasher BB; Roumiantsev S; Van Etten RA
Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
[TBL] [Abstract][Full Text] [Related]
8. Imatinib mesylate (STI571)-induced cell edge translocation of kinase-active and kinase-defective Abelson kinase: requirements of myristoylation and src homology 3 domain.
Fujita A; Shishido T; Yuan Y; Inamoto E; Narumiya S; Watanabe N
Mol Pharmacol; 2009 Jan; 75(1):75-84. PubMed ID: 18835981
[TBL] [Abstract][Full Text] [Related]
9. A fluorescence lifetime-based assay for abelson kinase.
Pritz S; Meder G; Doering K; Drueckes P; Woelcke J; Mayr LM; Hassiepen U
J Biomol Screen; 2011 Jan; 16(1):65-72. PubMed ID: 21148014
[TBL] [Abstract][Full Text] [Related]
10. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.
Nagar B; Hantschel O; Seeliger M; Davies JM; Weis WI; Superti-Furga G; Kuriyan J
Mol Cell; 2006 Mar; 21(6):787-98. PubMed ID: 16543148
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
Pisabarro MT; Serrano L; Wilmanns M
J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
[TBL] [Abstract][Full Text] [Related]
12. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.
Jackson PK; Paskind M; Baltimore D
Oncogene; 1993 Jul; 8(7):1943-56. PubMed ID: 8510937
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
Oda T; Kujovich J; Reis M; Newman B; Druker BJ
Oncogene; 1997 Sep; 15(11):1255-62. PubMed ID: 9315092
[TBL] [Abstract][Full Text] [Related]
14. Requirement of caspase-mediated cleavage of c-Abl during stress-induced apoptosis.
Machuy N; Rajalingam K; Rudel T
Cell Death Differ; 2004 Mar; 11(3):290-300. PubMed ID: 14657961
[TBL] [Abstract][Full Text] [Related]
15. Constitutive Activity in an Ancestral Form of Abl Tyrosine Kinase.
Aleem SU; Craddock BP; Miller WT
PLoS One; 2015; 10(6):e0131062. PubMed ID: 26090675
[TBL] [Abstract][Full Text] [Related]
16. Homo- and hetero-oligomerization of the c-Abl kinase and Abelson-interactor-1.
Fan PD; Cong F; Goff SP
Cancer Res; 2003 Feb; 63(4):873-7. PubMed ID: 12591740
[TBL] [Abstract][Full Text] [Related]
17. Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfolded.
Buffa P; Manzella L; Consoli ML; Messina A; Vigneri P
Proteins; 2007 Apr; 67(1):1-11. PubMed ID: 17211892
[TBL] [Abstract][Full Text] [Related]
18. Analysis of human c-Abl tyrosine kinase activity and regulation in S. pombe.
Walkenhorst J; Goga A; Witte ON; Superti-Furga G
Oncogene; 1996 Apr; 12(7):1513-20. PubMed ID: 8622867
[TBL] [Abstract][Full Text] [Related]
19. Protein tyrosine kinase-substrate interactions.
Bose R; Holbert MA; Pickin KA; Cole PA
Curr Opin Struct Biol; 2006 Dec; 16(6):668-75. PubMed ID: 17085043
[TBL] [Abstract][Full Text] [Related]
20. Homodimerization of the c-Abl protein tyrosine kinase.
Wei L; Liu X; Yi YP; Li CF; Wang YL; Cao C
Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):698-702. PubMed ID: 16285507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
